Marijuana and Cannabinoids

References

• Achiron , A. , Miron , S. , Lavie , V. , Margalit , R. and Biegon , A. 2000 . Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis . J Neuroimmunol , 102 ( 1 ) : 26 – 31 .
   PubMed Web of Science ®Google Scholar
• Arata , S. , Newton , C. , Klein , T. and Friedman , H. 1991 . Enhanced growth of Legionella pneumophila in tetrahydrocannabinol-treated macrophages . Proc Soc Exp Biol Med , 199 : 65 – 7 .
   Web of Science ®Google Scholar
• Baczynsky , W. O. T. and Zimmerman , A. M. 1983 . Effects of delta-9-tetrahydro-cannabinol, cannabinol and cannabidiol on the immune system in mice. In vitro investigation using cultured mouse splenocytes . Pharmacology , 26 ( 1 ) : 12 – 9 .
   PubMed Web of Science ®Google Scholar
• Baldwin , G. C. , Tashkin , D. P. , Buckley , D. M. , Park , A. M. , Dubinett , S. M. and Roth , M. D. 1997 . Marijuana and cocaine impair alveolar macrophage function and cytokine production . Am J Respir Crit Care Med , 156 ( 5 ) : 1606 – 13 .
   PubMed Web of Science ®Google Scholar
• Bass , R. , Engelhard , D. , Trembovler , V. and Shohami , E. 1996 . A novel nonpsycho-tropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis . J Infect Dis , 173 : 735 – 8 .
   PubMed Web of Science ®Google Scholar
• Berdyshev , E. V. , Boichot , E. , Germain , N. , Allain , N. , Anger , J. P. and Lagente , V. 1997 . Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells . Eur J Pharmacol , 330 ( 2–3 ) : 231 – 40 .
   PubMed Web of Science ®Google Scholar
• Bouaboula , M. , Poinot-Chazel , C. , Marchand , J. , Canat , X. , Bourrie , B. , Rinaldi-Carmona , M. , Calandra , B. , Le Fur , G. and Casellas , P. 1996 . Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression . Eur J Biochem , 237 ( 3 ) : 704 – 11 .
   PubMedGoogle Scholar
• Bouaboula , M. , Poinot-Chazel , C. , Bourrie , B. , Canat , X. , Calandra , B. , Rinaldi-Carmona , M. , Le Fur , G. and Casellas , P. 1995 . Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 . Biochem J , 312 : 637 – 41 .
   PubMed Web of Science ®Google Scholar
• Bouaboula , M. , Rinaldi , M. , Carayon , P. , Carillon , C. , Delpech , B. , Shire , D. , Le Fur , G. and Casellas , P. 1993 . Cannabinoid receptor expression in human leukocytes . Eur J Biochem , 214 : 173 – 80 .
   PubMedGoogle Scholar
• Buckley , N. E. , McCoy , K. L. , Mezey , E. , Bonner , T. , Zimmer , A. , Felder , C. C. , Glass , M. and Zimmer , A. 2000 . Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor . Eur J Pharmacol , 396 ( 2–3 ) : 141 – 9 .
   PubMed Web of Science ®Google Scholar
• Burnette-Curley , D. , Marciano , F. M. , Fischer , K. and Cabral , G. A. 1993 . Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of Bacillus Cal-métte-Guérin-activated macrophages . Int J Immunopharmacol , 15 : 371 – 82 .
   PubMed Web of Science ®Google Scholar
• Burstein , S. , Budrow , J. , Debatis , M. , Hunter , S. A. and Subramanian , A. 1994 . Phospholipase participation in cannabinoid-induced release of free arachidonic acid . Biochem Pharmacol , 48 : 1253 – 64 .
   PubMed Web of Science ®Google Scholar
• Cabral , G. A. and Pettit , D. Dove . 1998 . Drugs and immunity: Cannabinoids and their role in decreased resistance to infectious disease . J Neuroimmunol , 83 : 116 – 23 .
   PubMed Web of Science ®Google Scholar
• Cabral , G. A. and Fischer-Stenger , K. 1994 . Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol . Life Sci , 54 : 1831 – 44 .
   PubMed Web of Science ®Google Scholar
• Cabral , G. A. and Mishkin , E. M. 1989 . Delta-9-tetrahydrocannabinol inhibits macro-phage protein expression in response to bacterial immunomodulators . J Toxicol Environ Health , 26 : 175 – 82 .
   PubMed Web of Science ®Google Scholar
• Cabral , G. A. , McNerney , P. J. and Mishkin , E. M. 1987 . Effect of micromolar concentrations of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 replication in vitro . J Toxicol Environ Health , 21 ( 3 ) : 277 – 93 .
   PubMed Web of Science ®Google Scholar
• Cabral , G. A. , Lockmuller , J. C. and Mishkin , E. M. 1986a . Delta-9-tetrahydro-cannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse . Proc Soc Exp Biol Med , 181 : 305 – 11 .
   PubMed Web of Science ®Google Scholar
• Cabral , G. , Mishkin , E. M. , Marciano , F. M. , Coleman , R. E. , Harris , L. S. and Munson , A. E. 1986b . Effect of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig . Proc Soc Exp Biol Med , 182 : 181 – 6 .
   PubMed Web of Science ®Google Scholar
• Caiaffa , W. T. , Vlahov , D. , Graham , N. M. D. , Astemborski , J. , Solomon , L. , Nelson , K. E. and Munoz , A. 1994 . Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users . Am J Respir Crit Care Med , 150 : 1493 – 8 .
   PubMed Web of Science ®Google Scholar
• Childers , S. R. and Deadwyler , S. A. 1996 . Role of cyclic AMP in the actions of cannabinoid receptors . Biochem Pharmacol , 52 : 819 – 27 .
   PubMed Web of Science ®Google Scholar
• Clements , D. , Cabral , G. A. and McCoy , K. L. 1996 . Delta-9-tetrahydrocannabinol selectively inhibits macrophage co-stimulatory activity and down-regulates heat-stable antigen expression . J Pharmacol Exp Ther , 277 : 1315 – 21 .
   PubMed Web of Science ®Google Scholar
• del Arco , I. , Munoz , R. , Rodriguez De Fonseca , F. , Escudero , L. , Martin-Calderon , J. L. , Navarro , M. and Villanua , M. A. 2000 . Maternal exposure to the synthetic canna-binoid HU-210: effects on the endocrine and immune systems of the adult male offspring . Neuroimmunomodulation , 7 ( 1 ) : 16 – 26 .
   PubMed Web of Science ®Google Scholar
• Derocq , J. M. , Jbilo , O. , Bouaboula , M. , Segui , M. , Clere , C. and Casellas , P. 2000 . Genomic and functional changes induced by the activation of the peripheral canna-binoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation . J Biol Chem , 275 ( 21 ) : 15621 – 8 .
   PubMed Web of Science ®Google Scholar
• Derocq , J. M. , Segui , M. , Marchand , J. , Le Fur , G. and Casellas , P. 1995 . Cannabinoids enhance human B-cell growth at low nanomolar concentrations . FEBS Letters , 369 : 177 – 82 .
   PubMed Web of Science ®Google Scholar
• Desoize , B. , Leger , C. and Nahas , G. G. 1979 . Plasma membrane inhibition of macromolecular precursor transport by THC . Biochem Pharmacol , 28 : 1113 – 8 .
   PubMed Web of Science ®Google Scholar
• Dewey , W. L. 1986 . Cannabinoid pharmacology . Pharmacol Rev , 38 ( 2 ) : 151 – 78 .
   PubMed Web of Science ®Google Scholar
• DiFranco , M. J. , Sheppard , H. W. , Hunter , D. J. , Tosteson , T. D. and Ascher , M. S. 1996 . The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study . Ann Epidemiol , 6 ( 4 ) : 283 – 9 .
   PubMed Web of Science ®Google Scholar
• Pettit , Dove D.A. , Anders , D. L. , Harrison , M. P. and Cabral , G. A. 1996 . Cannabinoid receptor expression in immune cells . Adv Exp Med Biol , 402 : 119 – 29 .
   PubMedGoogle Scholar
• Drath , D. B. , Shorey , J. M. , Price , L. and Huber , G. L. 1979 . Metabolic and functional characteristics of alveolar macrophages recovered from rats exposed to marijuana smoke . Infect Immun , 25 : 268 – 72 .
   PubMed Web of Science ®Google Scholar
• Facci , L. , Dal Tosso , R. , Romanello , S. , Buriani , A. , Skaper , S. D. and Leon , A. 1995 . Mast cells express a peripheral receptor and differential sensitivity to anandamide and palmitoylethanolamide . Proc Natl Acad Sci USA , 92 : 3376 – 80 .
   PubMed Web of Science ®Google Scholar
• Faubert , B. L. and Kaminski , N. E. 2000 . AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun . J Leukoc Biol , 67 ( 2 ) : 259 – 66 .
   PubMed Web of Science ®Google Scholar
• Felder , C. C. , Joyce , K. E. , Briley , E. M. , Mansouri , J. , Mackie , K. , Blond , O. , Lai , Y. , Ma , A. L. and Mitchell , R. L. 1995 . Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors . Mol Pharmacol , 48 : 443 – 50 .
   PubMed Web of Science ®Google Scholar
• Felder , C. C. , Veluz , J. S. , Williams , H. L. , Briley , E. M. and Matsuda , L. A. 1992 . Cannabinoid agonists stimulate both receptorand non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones . Mol Pharmacol , 42 : 838 – 45 .
   PubMed Web of Science ®Google Scholar
• Fischer-Stenger , K. , Updegrove , A. W. and Cabral , G. A. 1992 . Delta-9-tetrahydro-cannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells . Proc Soc Exp Biol Med , 200 : 422 – 30 .
   PubMed Web of Science ®Google Scholar
• Friedman , H. and Klein , T. W. 1999 . Marijuana and immunity . Sci Med , 6 ( 2 ) : 12 – 21 .
   Google Scholar
• Galiègue , S. , Mary , S. , Marchand , J. , Dussosoy , D. , Carrière , D. , Carayon , P. , Bouaboula , M. , Shire , D. , Le Fur , G. and Casellas , P. 1995 . Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpop-ulations . Eur J Biochem , 232 : 54 – 61 .
   PubMedGoogle Scholar
• Gallily , R. , Yamin , A. , Waksmann , Y. , Ovadia , H. , Weidenfeld , J. , Bar-Joseph , A. , Biegon , A. , Mechoulam , R. and Shohami , E. 1997 . Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexan-abinol (HU-211), a nonpsychotropic cannabinoid . J Pharmacol Exp Ther , 283 ( 2 ) : 918 – 24 .
   PubMed Web of Science ®Google Scholar
• Gomez Del Pulgar , T. , Velasco , G. and Guzman , M. 2000 . The CB1 cannabinoid receptor is coupled to the activationof protein kinase B/Akt . Biochem J , 347 : 369 – 73 .
   PubMed Web of Science ®Google Scholar
• Gross , A. , Terraza , A. , Marchant , J. , Bouaboula , M. , Ouahrani-Bettache , S. , Liautard , J. P. , Casellas , P. and Dornand , J. 2000 . A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis. . J Leukoc Biol , 67 ( 3 ) : 335 – 44 .
   PubMed Web of Science ®Google Scholar
• Gross , G. , Roussaki , A. , Ikenberg , H. and Dress , N. 1991 . Genital warts do not respond to systemic recombinant interferon alpha-2a treatment during cannabis consumption . Dermatologica , 183 : 203 – 7 .
   PubMedGoogle Scholar
• Gupta , G. , Grieco , M. and Cushman , P. 1974 . Impairment of rosette-forming T-lym-phocytes in chronic marihuana smokers . New Eng J Med , 291 : 874 – 6 .
   PubMed Web of Science ®Google Scholar
• Herring , A. C. and Kaminski , N. E. 1999 . Cannabinol-mediated inhibition of nuclear factor-kappa B, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes . J Pharmacol Exp Ther , 291 ( 3 ) : 1156 – 63 .
   PubMed Web of Science ®Google Scholar
• Howlett , A. C. 1985 . Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes . Mol Pharmacol , 27 : 429 – 36 .
   PubMed Web of Science ®Google Scholar
• Howlett , A. C. 1984 . Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds . Life Sci , 35 : 1803 – 10 .
   PubMed Web of Science ®Google Scholar
• Howlett , A. C. and Fleming , R. M. 1984 . Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes . Mol Pharmacol , 26 : 532 – 8 .
   PubMed Web of Science ®Google Scholar
• Howlett , A. C. , Champion , T. M. , Wilken , G. H. and Mechoulam , R. 1990 . Stereo-chemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenyl cyclase and bind to the cannabinoid receptor . Neuropharmacol , 29 : 161 – 5 .
   PubMed Web of Science ®Google Scholar
• Howlett , A. C. , Qualy , J. M. and Khachchatrian , L. L. 1986 . Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs . Mol Pharmacol , 29 : 307 – 13 .
   PubMed Web of Science ®Google Scholar
• Jeon , Y. J. , Yang , K. H. , Pulaski , J. T. and Kaminski , N. E. 1996 . Attenuation of induc-ible nitric oxide gene expression by ?9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-?B/rel activation . Mol Pharmacol , 50 : 334 – 41 .
   PubMed Web of Science ®Google Scholar
• Johnson , T. E. , Casiano , R. R. , Kronish , J. W. , Tse , D. T. , Meldrum , M. and Chang , W. 1999 . Sino-orbital aspergillosis in acquired immunodeficiency syndrome . Arch Ophthalmol , 117 ( 1 ) : 57 – 64 .
   PubMed Web of Science ®Google Scholar
• Kaminski , N. E. , Abood , M. E. , Kessler , F. K. , Martin , B. R. and Schatz , A. R. 1992 . Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation . Mol Pharmacol , 42 : 736 – 42 .
   PubMed Web of Science ®Google Scholar
• Kaminski , N. E. , Koh , W. S. , Yang , K. H. , Lee , M. and Kessler , F. K. 1994 . Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism . Biochem Pharmacol , 48 : 1899 – 908 .
   PubMed Web of Science ®Google Scholar
• Kawakami , Y. , Klein , T. W. , Newton , C. , Djeu , J. Y. , Specter , S. and Friedman , H. 1988 . Suppression of delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity . Int J Immunopharmacol , 10 : 485 – 8 .
   PubMed Web of Science ®Google Scholar
• Klein , T. W. , Newton , C. A. , Nakachi , N. and Friedman , H. 2000 . Delta 9-tetra-hydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection . J Immunol , 164 ( 12 ) : 6461 – 6 .
   PubMed Web of Science ®Google Scholar
• Klein , T. W. , Newton , C. and Friedman , H. 1994 . Resistance to Legionella pneumo-phila suppressed by the marijuana component, tetrahydrocannabinol . J Infect Dis , 169 : 1177 – 9 .
   PubMedGoogle Scholar
• Klein , T. , Newton , C. , Widen , R. and Friedman , H. 1993 . Delta-9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. . J Pharmacol Exp Ther , 267 : 635 – 40 .
   PubMed Web of Science ®Google Scholar
• Klein , T. W. , Kawakami , Y. , Newton , C. and Friedman , H. 1991 . Marijuana components supress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. . J Toxicol Environ Health , 32 : 465 – 77 .
   PubMed Web of Science ®Google Scholar
• Klein , T. W. and Friedman , H. 1990 . Drugs of abuse and immune function , Edited by: Watson , R. R. Boca Raton : CRC Press .
   Google Scholar
• Klein , T. W. , Newton , C. and Friedman , H. 1987 . Inhibition of natural killer cell function by marijuana components . J Toxicol Environmental Health , 20 : 321 – 32 .
   PubMed Web of Science ®Google Scholar
• Klein , T. W. , Newton , C. , Widen , R. and Friedman , H. 1985 . The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta 9-tetrahydrocannabinol on T-lympho-cyte and B-lymphocyte mitogen responses . J Immunopharmacol , 7 : 451 – 66 .
   PubMed Web of Science ®Google Scholar
• Klykken , P. C. , Smith , S. H. , Levy , J. A. , Razdan , R. and Munson , A. E. 1977 . Immunosuppressive effects of 8,9-epoxyhexahydrocannabinol (EHHC) . J Pharmacol Exp Ther , 201 : 573 – 9 .
   PubMed Web of Science ®Google Scholar
• Kusher , D. I. , Dawson , L. O. , Taylor , A. C. and Djeu , J. Y. 1994 . Effect of the psycho-active metabolite of marijuana, delta-9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by large granular lymphocytes . Cellular Immunol , 154 ( 1 ) : 99 – 108 .
   PubMed Web of Science ®Google Scholar
• Lee , M. , Yang , K. H. and Kaminski , N. E. 1995 . Effects of putative receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes . J Pharmacol Exp Ther , 275 : 529 – 36 .
   PubMed Web of Science ®Google Scholar
• Lopez-Cepero , M. , Friedman , M. , Klein , T. and Friedman , H. 1986 . Tetrahydro-cannabinol-induced suppression of macrophage spreading and phagocyte activity in vitro. . J Leukoc Biol , 39 : 679 – 86 .
   PubMed Web of Science ®Google Scholar
• Lynn , A. B. and Herkenham , M. 1994 . Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids . J Pharmacol Exp Ther , 268 : 1612 – 23 .
   PubMed Web of Science ®Google Scholar
• Mackie , K. and Hille , B. 1992 . Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells . Proc Natl Acad Sci USA , 89 : 3825 – 9 .
   PubMed Web of Science ®Google Scholar
• Malfait , A. M. , Gallily , R. , Sumariwalla , P. F. , Malik , A. S. , Andreakos , E. , Mechoulam , R. and Feldmann , M. 2000 . The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis . Proc Natl Acad Sci USA , 97 ( 17 ) : 9561 – 6 .
   PubMed Web of Science ®Google Scholar
• Mann , P. E. G. , Cohen , A. B. , Finley , T. N. and Ladman , A. J. 1971 . Alveolar macrophages. Structural and functional differences between non-smokers and smokers of marijuana in vitro . Lab Invest , 25 : 111 – 20 .
   PubMed Web of Science ®Google Scholar
• Massi , P. , Fuzio , D. , Vigano , D. , Sacerdote , P. and Parolaro , D. 2000 . Relative involvement of cannabinoid CB(1) and CB(2) receptors in Delta(9)-tetrahydrocanna-binol-induced inhibition of natural killer activity . Eur J Pharmacol , 387 ( 3 ) : 343 – 7 .
   PubMed Web of Science ®Google Scholar
• Massi , P. , Sacerdote , P. , Ponti , W. , Fuzio , D. , Manfredi , B. , Vigano , D. , Rubino , T. , Bardotti , M. and Parolaro , D. 1998 . Immune function alterations in mice tolerant to delta-9-tetrahydrocannabinol: functional and biochemical parameters . J Neuro-immunol , 92 ( 1–2 ) : 60 – 6 .
   PubMed Web of Science ®Google Scholar
• Matsuda , L. A. , Lolait , S. J. , Brownstein , M. J. , Young , A. C. and Bonner , T. I. 1990 . Structure of a cannabinoid receptor and functional expression of the cloned cDNA . Nature , 346 : 561 – 4 .
   PubMed Web of Science ®Google Scholar
• Matveyeva , M. , Hartman , C. B. , Harrison , M. T. , Cabral , G. A. and McCoy , K. L. 2000 . Delta (9)-tetrahydrocannabinol selectively increases aspartyl cathepsin D proteolytic activity and impairs lysozyme processing by macrophages . Int J Immunopharmacol , 22 ( 5 ) : 373 – 81 .
   PubMed Web of Science ®Google Scholar
• McCoy , K. L. , Gainey , D. and Cabral , G. A. 1995 . ?9-Tetrahydrocannabinol modulates antigen processing by macrophages . J Pharmacol Exp Ther , 273 : 1216 – 23 .
   PubMed Web of Science ®Google Scholar
• McCoy , K. L. , Matveyeva , M. , Carlisle , S. J. and Cabral , G. A. 1999 . Cannabinoid inhibition of the processing of intact lysozyme by macrophages: Evidence for CB2 receptor participation . J Pharmacol Exp Ther , 289 : 1620 – 5 .
   PubMed Web of Science ®Google Scholar
• Miller , J. M. Jr. and Goodridge , C. 2000 . Antenatal marijuana use is unrelated to sexually transmitted infections during pregnancy . Infect Dis Obstet Gynecol , 8 ( 3–4 ) : 155 – 7 .
   PubMedGoogle Scholar
• Mishkin , E. M. and Cabral , G. 1985 . Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse . J Gen Virol , 66 : 2539 – 49 .
   PubMed Web of Science ®Google Scholar
• Molina-Holgado , F. , Lledo , A. and Guaza , C. 1997 . Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes . Neuro-report , 8 ( 8 ) : 1929 – 33 .
   PubMed Web of Science ®Google Scholar
• Morahan , P. S. , Klykken , P. C. , Smith , S. H. , Harris , L. S. and Munson , A. E. 1979 . Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus . Inf Immun , 23 : 670 – 4 .
   PubMed Web of Science ®Google Scholar
• Munro , S. , Thomas , K. L. and Abu-Shaar , M. 1993 . Molecular characterization of a peripheral receptor for cannabinoids . Nature , 365 : 61 – 5 .
   PubMed Web of Science ®Google Scholar
• Munson , A. E. , Levy , J. A. , Harris , L. S. and Dewey , W. L. 1976 . “ Effects of delta 9-tetrahydrocannabinol on the immune system ” . In The Pharmacology of Marijuana , Edited by: Braude , M. C. and Szara , S. New York : Raven Press .
   Google Scholar
• Munson , A. E. and Fehr , K. O. 1983 . “ Immunological Effects of Cannabis ” . In Cannabis and Health Hazards , Edited by: Fehr , K. O. and Kalant , H. Toronto : Alcoholism and Drug Addiction Research Foundation .
   Google Scholar
• Nahas , G. G. , Morishima , A. and Desoize , B. 1977 . Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes . Fed Proc , 36 : 1748 – 52 .
   PubMedGoogle Scholar
• Nahas , G. G. and Osserman , E. F. 1991 . Altered serum immunoglobulin concentration in chronic marijuana smokers . Adv Exp Med Biol , 288 : 25 – 32 .
   PubMedGoogle Scholar
• Nahas , G. G. , Suciu-Foca , N. , Armand , J. P. and Morishima , A. 1974 . Inhibition of cellular mediated immunity in marihuana smokers . Science , 183 : 419 – 20 .
   PubMed Web of Science ®Google Scholar
• Netzeband , J. G. , Conroy , S. M. , Parsons , K. L. and Gruol , D. L. 1999 . Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture . J Neurosci , 19 : 8765 – 77 .
   PubMed Web of Science ®Google Scholar
• Newton , C. , Klein , T. and Friedman , H. 1998 . The role of macrophages in THC-in-duced alteration of the cytokine network . Adv Exp Med Biol , 437 : 207 – 14 .
   PubMed Web of Science ®Google Scholar
• Newton , C. A. , Klein , T. W. and Friedman , H. 1994 . Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection . Inf Immun , 62 : 4015 – 20 .
   PubMed Web of Science ®Google Scholar
• Noe , S. N. , Nyland , S. B. , Ugen , K. , Friedman , H. and Klein , T. W. 1998 . Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN . Adv Exp Med Biol , 437 : 223 – 9 .
   PubMed Web of Science ®Google Scholar
• Patel , V. , Borysenko , M. , Kumar , M. S. A. and Millard , W. J. 1985 . Effects of acute and subchronic delta-9-tetrahydrocannabinol administration on the plasma catecholamine, beta-endorphin, and corticosterone levels and splenic natural killer cell activity in rats . Proc Soc Exp Biol Med , 180 : 400 – 4 .
   PubMed Web of Science ®Google Scholar
• Persaud , N. E. , Klaskala , W. , Tewari , T. , Schultz , J. and Baum , M. 1999 . Drug use and syphilis. Co-factors for HIV transmission among commercial sex workers in Guyana . West Indian Med J , 48 ( 2 ) : 52 – 6 .
   PubMed Web of Science ®Google Scholar
• Peterson , B. H. , Graham , J. and Lemberger , L. 1976 . Marihuana, tetrahydrocannabinol and T-cell function . Life Sci , 19 : 395 – 400 .
   PubMed Web of Science ®Google Scholar
• Pross , S. H. , Nakano , Y. , Widen , R. , McHugh , S. , Newton , C. A. , Klein , T. W. and Friedman , H. 1992 . Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators . Int J Immunopharmacol , 14 : 1019 – 27 .
   PubMed Web of Science ®Google Scholar
• Ramarathinam , L. , Pross , S. , Plescia , O. , Newton , C. , Widen , R. and Friedman , H. 1997 . Differential immunologic modulatory effects of tetrahydrocannabinol as a function of age . Mech Ageing Dev , 96 ( 1–3 ) : 117 – 26 .
   PubMed Web of Science ®Google Scholar
• Rinaldi-Carmona , M. , Barth , F. , Héaulme , M. , Shire , D. , Calandra , B. , Congy , C. , Martinez , S. , Maruani , J. , Néliat , G. , Caput , D. , Ferrara , P. , Soubrié , P. , Breliére , J. C. and Le Fur , G. 1994 . Sr141716A, a potent and selective antagonist of the brain canna-binoid receptor . FEBS Letters , 350 : 240 – 4 .
   PubMed Web of Science ®Google Scholar
• Rinaldi-Carmona , M. , Barth , F. , Millan , J. , Derocq , J. M. , Casellas , P. , Congy , C. , Oustric , D. , Sarran , M. , Bouaboula , M. , Calandra , B. , Portier , M. , Shire , D. , Breliére , J. and Le Fur , G. 1998 . SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor . J Pharmacol Exp Ther , 284 : 644 – 50 .
   PubMed Web of Science ®Google Scholar
• Shohami , E. , Gallily , R. , Mechoulam , R. , Bass , R. and Ben-Hur , T. 1997 . Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant . J Neuroimmunol , 72 ( 2 ) : 169 – 77 .
   PubMed Web of Science ®Google Scholar
• Simeon , D. T. , Bain , B. , Wyatt , G. E. , LeFranc , E. , Ricketts , H. , Chambers , C. C. and Tucker , M. B. 1996 . Characteristics of Jamaicans who smoke marijuana before sex and their risk status for sexually transmitted diseases . West Indian Med J , 45 ( 1 ) : 9 – 13 .
   PubMed Web of Science ®Google Scholar
• Smith , S. R. , Terminelli , C. and Denhardt , G. 2000 . Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice . J Pharmacol Exp Ther , 293 ( 1 ) : 136 – 50 .
   PubMed Web of Science ®Google Scholar
• Smith , S. H. , Harris , L. S. , Uwaydah , I. M. and Munson , A. E. 1978 . Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity . J Pharmacol Exp Ther , 207 : 165 – 70 .
   PubMed Web of Science ®Google Scholar
• Specter , S. C. , Klein , T. W. , Newton , C. , Mondragon , M. , Widen , R. and Friedman , H. 1986 . Marijuana effects on immunity:suppression of human natural killer cell activity by delta-9-tetrahydrocannabinol . Int J Immunopharmacol , 8 : 741 – 5 .
   PubMed Web of Science ®Google Scholar
• Specter , S. , Lancz , G. , Westrich , G. and Friedman , H. 1991 . Delta-9-tetrahydro-cannabinol augments murine retroviral induced immunosuppression and infection . Int J Immunopharmacol , 13 : 411 – 7 .
   PubMedGoogle Scholar
• Srivastava , M. D. , Srivastava , B. I. and Brouhard , B. 1998 . Delta-9-tetrahydro-cannabinol and cannabidiol alter cytokine production by human immune cells . Immunopharmacology , 40 ( 3 ) : 179 – 85 .
   PubMed Web of Science ®Google Scholar
• Stefano , G. B. , Salzet , M. and Bilfinger , T. V. 1998 . Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release . J Cardiovasc Pharmacol , 31 ( 6 ) : 862 – 8 .
   PubMed Web of Science ®Google Scholar
• Stefano , G. B. , Liu , Y. and Goligorsky , M. S. 1996 . Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human mono-cytes . J Biol Chem , 271 : 19238 – 42 .
   PubMed Web of Science ®Google Scholar
• Timpone , J. G. , Wright , D. J. , Li , N. , Egorin , M. J. , Enama , M. E. , Mayers , J. and Galetto , J. 1997 . The safety and pharmokinetics of single-agent and combination therapy with Megestrol acetate and Dronabinol for the treatment of HIV wasting syndrome . AIDS Res Hum Retroviruses , 13 : 305 – 15 .
   PubMed Web of Science ®Google Scholar
• Tindall , B. , Cooper , D. A. , Donovan , B. , Barnes , T. , Philpot , C. R. , Gold , J. and Penny , R. 1988 . The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group ofHIV seropositive homosexual men . AustN Z J Med , 18 ( 1 ) : 8 – 15 .
   PubMedGoogle Scholar
• Waksman , Y. , Olson , J. M. , Carlisle , S. J. and Cabral , G. A. 1999 . The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells . J Pharmacol Exp Ther , 288 : 1357 – 66 .
   PubMed Web of Science ®Google Scholar
• Wallace , J. M. , Lim , R. , Browdy , B. L. , Hopewell , P. C. , Glassroth , J. , Rosen , M. J. , Reichman , L. B. and Kvale , P. A. 1998 . Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary complications of HIV infection study group . Chest , 114 ( 1 ) : 131 – 7 .
   PubMed Web of Science ®Google Scholar
• Whitfield , R. M. , Bechtel , L. M. and Starich , G. H. 1997 . The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy . Alcohol Clin Exp Res , 21 ( 1 ) : 122 – 7 .
   PubMed Web of Science ®Google Scholar
• Wing , D. R. , Leuschner , J. T. A. , Brent , G. A. , Harvey , D. J. and Paton , W. D.M. . Quantification of in vivo membrane associated delta-9-tetrahydrocannabinol and its effects on membrane fluidity . Proceedings of the 9th International Congress of Pharmacology 3rd satellite symposium on cannabis . Edited by: Harvey , D. J. Oxford : IRL Press .
   Google Scholar
• Zhu , L. X. , Sharma , S. , Stolina , M. , Gardner , B. , Roth , M. D. , Tashkin , D. P. and Dubinett , S. M. 2000 . Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway . J Immunol , 165 ( 1 ) : 373 – 80 .
   PubMed Web of Science ®Google Scholar
• Zimmerman , S. , Zimmerman , A. M. , Cameron , I. L. and Lawrence , H. L. 1977 . Delta1-tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice . Pharmacology , 15 : 10 – 23 .
   PubMed Web of Science ®Google Scholar